Targeted DNA Nanomachine Enables Specific miRNA‐Responsive Singlet Oxygen Amplification for Precise Cutaneous Squamous Cancer Therapy
Advanced Science · 2025
DOI: 10.1002/advs.202415296 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Hanane Aliouat und 9 weiteren Autor:innen. Beteiligte Einrichtung: Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, 410013, China. Hauptthemen laut MEDLINE: MicroRNAs, Skin Neoplasms, Photochemotherapy, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, Furong Laboratory Research Project of Hunan Province.
Abstract (Originalsprache)
Photodynamic therapy (PDT) is a promising strategy for the treatment of skin‐related tumors including cutaneous squamous cells carcinoma (cSCC). However, it is hard to balance the dosage off‐target phototoxicity while maintaining satisfactory therapeutic effect. In addition, oxygen‐dependent photosensitizers (PSs) are affected by tumor hypoxic environment, which further causes inefficient photocatalysis and reduces therapeutic effect. Herein, an intelligent DNA nanomachine based on tetrahedral DNA framework is proposed, incorporated with tumor‐targeted aptamer and specific miRNA‐responsive hairpin DNA catalytic assembly (HCA), for precise and high‐efficient therapy of cSCC. After aptamer‐mediated targeted delivery, a cSCC‐specific miRNA selected by tissue sequencing analysis is used to activateHCA, for amplifying PSs and controllably releasing chemotherapeutic drugs. Sequential recognition can greatly improve tumor‐specific accumulation and high‐dose activation. Moreover, hemin is incorporated into DNA to catalytically produce oxygen. In vitro and in vivo experiments demonstrated that this DNA nanomachine greatly improved anti‐tumor effect and realized effective ablation of cSCC in mice, with barely systemic toxicity and inflammation. It is anticipated that this strategy will promote biomedical applications of tumor‐specific miRNA and provide a promising option for the non‐invasive treatment of skin‐associated tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, 410013, China.
- Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
- Hangzhou Innovation Institute, Beihang University, Hangzhou, Zhejiang, 310053, China.
ORCID-Profile: Nuli Xie
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
- Furong Laboratory Research Project of Hunan Province
Zitieren
APA
Aliouat, H., Zhang, D., Peng, L., Huang, J., Cheng, H., Zhu, J., Chen, X., Xie, N., Zhou, W., & Zhao, S. (2025). Targeted DNA Nanomachine Enables Specific miRNA‐Responsive Singlet Oxygen Amplification for Precise Cutaneous Squamous Cancer Therapy. Advanced Science. https://doi.org/10.1002/advs.202415296
Vancouver
Aliouat H, Zhang D, Peng L, Huang J, Cheng H, Zhu J, et al. Targeted DNA Nanomachine Enables Specific miRNA‐Responsive Singlet Oxygen Amplification for Precise Cutaneous Squamous Cancer Therapy. Advanced Science. 2025. doi:10.1002/advs.202415296
BibTeX
@article{Aliouat2025,
author = {Aliouat, Hanane and Zhang, Detian and Peng, Lanyuan and Huang, Jiaxin and Cheng, Hongshi and Zhu, Jiaojiao and Chen, Xiang and Xie, Nuli and Zhou, Wenhu and Zhao, Shuang},
title = {Targeted DNA Nanomachine Enables Specific miRNA‐Responsive Singlet Oxygen Amplification for Precise Cutaneous Squamous Cancer Therapy},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202415296}
}
EUVIMED